SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001381
Filing Date
2021-08-12
Accepted
2021-08-12 16:40:37
Documents
87
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20210630.htm   iXBRL 10-Q 2673523
2 EX-31.1 acet-20210630ex31_1.htm EX-31.1 14916
3 EX-31.2 acet-20210630ex31_2.htm EX-31.2 15369
4 EX-32.1 acet-20210630ex32_1.htm EX-32.1 13042
  Complete submission text file 0000950170-21-001381.txt   9948788

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20210630_pre.xml EX-101.PRE 411664
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acet-20210630_def.xml EX-101.DEF 233594
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20210630.xsd EX-101.SCH 72614
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20210630_lab.xml EX-101.LAB 542501
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acet-20210630_cal.xml EX-101.CAL 55621
10 EXTRACTED XBRL INSTANCE DOCUMENT acet-20210630_htm.xml XML 1903896
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 211168254
SIC: 2834 Pharmaceutical Preparations